OKYO · Forms 3, 4, 5
Insider trades at OKYO Pharma Ltd
No open-market insider buys or sells at OKYO Pharma Ltd in the last 90 days; 7 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for OKYO Pharma Ltd (OKYO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rajkumar V. Patil | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Rajkumar V. Patil | Chief Scientific Officer | Award | 3,363 | $1.49 | $5K | Form 4 | |
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER | Award | 15,000 | $1.54 | $23K | Form 4 | |
| Gabriele M Cerrone | Director | Award | 22,500 | $1.45 | $33K | Form 4 | |
| Gary S Jacob | CHIEF DEVELOPMENT OFFICER | Award | 3,500 | $1.40 | $5K | Form 4 | |
| John P Brancaccio | Director | Award | 5,000 | $1.48 | $7K | Form 4 | |
| Flavio Mantelli | CHIEF MEDICAL OFFICER | Award | 20,000 | $1.40 | $28K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.